However, we assume that the multidisciplinary approach to treating women with VWD (involving a hematologist and obstetrician, regular measurements of VWF and FVIII levels postpartum, and appropriate treatment) contributes to the lower incidence of bleeding complications in the late postpartum period. This evidence concerns the gene VWF and von Willebrand disease (hereditary or acquired).